Hologic, Inc. (HOLX)

80,50 +1,30 (+1,64 %) À la clôture : 04:00PM EDT

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508 263 2900
https://www.hologic.com

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 6 944

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Stephen P. MacMillan	Chairman, CEO & Pres	4,51M	S.O.	1964
Ms. Karleen M. Oberton	Chief Financial Officer	1,6M	S.O.	1971
Mr. John M. Griffin	Gen. Counsel	1,56M	1,73M	1961
Mr. Kevin R. Thornal	Group Pres of Global Diagnostic Solutions	1,66M	595,56k	1974
Mr. Paul Malenchini	Chief Information Officer	S.O.	S.O.	S.O.
Ryan M. Simon	VP of Investor Relations	S.O.	S.O.	S.O.
Ms. Elisabeth A. Hellmann	Sr. VP of Global HR & Corp. Communications	S.O.	S.O.	1969
Mr. Jan Verstreken	Group Pres of International	S.O.	S.O.	1968
Ms. Monica Aguirre Berthelot	VP & Chief of Staff	S.O.	S.O.	S.O.
Mr. Mike Kelly	Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Hologic, Inc. en date du 1 mars 2023 est 7. Les scores principaux sont Audit : 7; Société : 8; Droits des actionnaires : 7; Compensation : 5.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.